OUP Management Co., LLC
Regulatory profile
From Form ADV, the SEC filer profile, 13D/13G type codes and N-CEN, never from the name.
Portfolio style
Measured from the filed 13F common-share book for Sep 30, 2023, never from the firm's own description.
Closest benchmark: the Russell 2000 as of 2023-09-30, active share 100.0%; sector active share 75.3% against the combined 13F book's sector weights.
Over time 8 measured quarters
How the bands are measured
Style bands measure the filed 13F common-share book each closed quarter, tested in this order. Unknown: under $10,000,000 of valued equity or 5 stocks. Index-like (100+ stocks): active share of 20% or less against the closest benchmark, which is the S&P 500, S&P MidCap 400, S&P SmallCap 600, Russell 1000, Russell 2000, Nasdaq-100 or Dow Jones Industrial Average (weighted by an index-tracking fund's reported holdings or the index's constituents nearest the quarter end, over the names resolved to companies, and only when those are 90%+ of its weight) or every 13F filer's combined book, or index series holding 80%+ of the registered fund assets it advises (N-CEN) and equal to 50%+ of its book. Systematic-like: 500+ stocks, 100%+ annual turnover and a top 10 weight of 25% or less. Concentrated: a top 10 weight of 60%+ or 12 or fewer effective positions. Diversified active: none of these. Turnover is the smaller of buys and sells over average equity value, summed over four quarters: low under 30%, high 100%+. Horizon is the value-weighted number of quarters each position has been held: short under 4, long 12+.
Clone Performance
Build a hypothetical price-return history from this filer's public 13F holdings.
View clone backtestPortfolio Concentration
11 tracked positions · as of Sep 30, 2023 · Δ vs Jun 30, 2023Portfolio Trend
Sector Breakdown
As of Sep 30, 2023| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 84.0% | $36,790,450 |
| Unclassified | 16.0% | $6,985,184 |
Last Quarter's Activity
Export CSVAdded To
Positions the filer increasedTrimmed
Positions the filer reducedNew Positions
Positions the filer opened this quarter| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| IKNA | ImageneBio, Inc. | 26,833 | $116,187 | |
| No positions match the current search. | ||||
Sold Out
Positions the filer fully exited| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| — | 268,346 | $12,467,355 | ||
| No positions match the current search. | ||||
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| CNTA |
Centessa Pharmaceuticals plc
Healthcare
|
Held | 2,937,615 | $19,006,369 | 43.42% | |
| AVTE |
Jade Biosciences, Inc.
Healthcare
|
Held | 603,762 | $8,193,050 | 18.72% | |
|
|
Held | 2,459,572 | $6,985,184 | 15.96% | ||
| PMVP |
PMV Pharmaceuticals, Inc.
Healthcare
|
Held | 989,232 | $6,073,884 | 13.88% | |
| GRPH |
LENZ Therapeutics, Inc.
Healthcare
|
Held | 406,308 | $1,007,644 | 2.30% | |
| RNAC |
Cartesian Therapeutics, Inc.
Healthcare
|
Held | 862,543 | $914,295 | 2.09% | |
| VOR |
Vor Biopharma Inc.
Healthcare
|
Held | 374,714 | $794,393 | 1.81% | |
| DTIL |
Precision Biosciences Inc
Healthcare
|
Held | 1,123,913 | $383,254 | 0.88% | |
| SPRO |
Spero Therapeutics, Inc.
Healthcare
|
Held | 249,070 | $301,374 | 0.69% | |
| IKNA |
ImageneBio, Inc.
Healthcare
|
NEW | 26,833 | $116,187 | 0.27% | |
| FIXX |
|
Held | 64,000 | $0 | 0.00% |
Covers the securities this platform tracks: U.S.-listed common stock and the put/call positions reported on it. A 13F can also report security types outside that coverage — preferred shares, bonds, warrants, untracked share classes — so the filing's own declared total can exceed the figures above. The source filing is linked at the top of this table.